2012年-世界发展银行全球_Health_Costs_and_Benefits_of_DDT_Use_in_Malaria_Control_and_Prevention_32页_648kb

Summary of "Health Costs and Benefits of DDT Use in Malaria Control and Prevention"

Core Content

This paper evaluates the health costs and benefits of using DDT in indoor residual spraying (IRS) for malaria control, focusing on its impact on human health and the economy. It aims to quantify the health externalities associated with DDT use and compare them with the economic benefits of malaria prevention.

Main Points

• DDT and Malaria Control: DDT is a highly effective insecticide used in IRS to combat malaria. It has been endorsed by WHO for its insecticidal activity, low mammalian toxicity, and cost-effectiveness.
• Health Risks of DDT: DDT is classified as a Class II "moderately hazardous" substance. Its persistent and bio-accumulative nature leads to various health risks, including cancer, diabetes, reproductive issues, and neurodevelopmental deficits.
• Exposure Pathways: DDT exposure can occur through contaminated food, breast milk, soil, and air/water near sprayed areas. The highest exposure is among IRS spray operators and directly exposed households.
• Population Exposure: DDT use is primarily concentrated in high malaria endemicity areas, which are categorized by Plasmodium falciparum parasite rate (PfPR): low (<5%), medium (5%-40%), and high (>40%).
• Economic Impact: The paper estimates both direct and indirect costs of DDT-related health issues and compares them with the economic benefits of reducing malaria incidence.

Key Findings

Global Perspective

• The global population exposed to DDT is estimated at around 1.25 billion.
• DDT use can reduce the estimated $69 billion annual economic loss from malaria.
• However, it can also lead to an additional $28 billion in annual health costs due to its adverse effects.

Country-Level Analysis

• Sub-Saharan African Countries: These countries, which have high malaria incidence rates, are likely to see relatively larger net benefits from DDT use.
• DDT Use Scenarios:
  • Widespread Use: Results in increased direct costs of over $3.03 billion and indirect costs of more than $24.92 billion annually.
  • Restricted Use: Leads to lower costs, with direct costs of nearly $0.60 billion and indirect costs of nearly $4.58 billion annually.
• Cost Estimation Methodology:
  • Direct Costs: Based on treatment costs for diseases caused by DDT exposure.
  • Indirect Costs: Based on Disability Adjusted Life Years (DALY) lost due to malaria and DDT-related illnesses.

Methodology

• Data Sources: The study uses data from the Malaria Atlas Project (MAP) and WHO reports.
• Exposure Groups: Three population groups are considered:
  • IRS spray operators
  • Directly exposed households
  • Non-IRS exposed population
• Cost Calculation:
  • Direct costs are calculated based on treatment expenses.
  • Indirect costs are derived using DALYs and converted to monetary values using PPP GDP.

Conclusion

• The paper emphasizes the need to weigh the health costs and benefits of DDT use in malaria control programs.
• It suggests that while DDT can significantly reduce malaria-related economic losses, the health externalities must be carefully considered.
• The results indicate that the net health benefits of reintroducing DDT may vary by country and depend on local conditions, including malaria endemicity and exposure levels.

Key Information

• DDT Use: Currently used in 73 countries, including 36 in Africa, and under consideration for re-introduction in Sub-Saharan Africa.
• Health Externalities: Include cancer, diabetes, reproductive issues, and neurodevelopmental deficits.
• Economic Impact:
  • Direct Costs: Estimated at $3.03 billion (widespread) and $0.60 billion (restricted) annually.
  • Indirect Costs: Estimated at $24.92 billion (widespread) and $4.58 billion (restricted) annually.
• Malaria Costs:
  • Direct Cost Savings: Estimated at $1.08 billion if malaria is fully eradicated in identified countries.
  • Indirect Cost Savings: Estimated at $67.94 billion globally and over $34 billion in high endemicity areas.

Figures and Tables

• Figure 1: Country-level estimates of population exposure to DDT based on malaria endemicity.
• Figure 2: Illustrative example of increased direct costs from DDT exposure in Sub-Saharan Africa.
• Figure 3: Illustrative example of increased indirect costs from DDT exposure in Sub-Saharan Africa.
• Table 1: Summary exposure assessments by population groups.
• Table 2: Estimated risks of diseases based on DDT exposure.
• Table 3: Vulnerable population estimates by malaria intensity categories.
• Table 4: Summary of health and economic impacts.

This study provides a comprehensive analysis of the trade-offs between the benefits of DDT in malaria control and its associated health costs, offering insights for policymakers in making informed decisions.